Twelve years of multiples investors have paid for GANESHCP, framed against the sector median so the premium or discount is obvious at a glance.
GANESHCP trades at a P/E of 18.00× and P/B of 2.16×, against the Consumer Defensive sector median P/E of 33.39×.
Twelve years of audited numbers for GANESHCP, switchable between annual and quarterly views, consolidated or standalone.
GANESHCP reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹800.26 Cr and reported EPS of ₹11.04.
Disclosed business segments at GANESHCP with their share of revenue and profit, switchable between consolidated and standalone reporting.
GANESHCP discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy GANESHCP, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
No strengths or opportunities on record.
No weaknesses or threats on record.
Trim if P/E re-rates above 23 (~0.7× the sector multiple of 33.4). The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 7.67. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 9%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — GANESHCP is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for GANESHCP — derived from the live tape, not yesterday's close.
GANESHCP last traded at ₹198.7 with an intraday range of ₹198.02–₹204.75 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 216.42 | +17.72 | +8.92% |
| R3 | 209.69 | +10.99 | +5.53% |
| R2 | 207.22 | +8.52 | +4.29% |
| R1 | 202.96 | +4.26 | +2.14% |
| PIVOT | 200.49 | 1.79 | 0.90% |
| CURRENT | 198.70 | — | — |
| S1 | 182.77 | -15.93 | -8.02% |
| S2 | 189.50 | -9.20 | -4.63% |
| S3 | 193.76 | -4.94 | -2.49% |
| S4 | 196.23 | -2.47 | -1.24% |
GANESHCP is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 200.29 ~ 204.75
Trading Inside opening range
Daily traded volume and delivery percentage for GANESHCP over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in GANESHCP stood at 62.9% of traded volume, against a 20-day average of 53.5%.
Filings GANESHCP sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
GANESHCP files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 61 documents below.
GANESHCP: Disclosure of Acquisition of Securities under regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider…
Ganesh Consumer Products Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of…
Ganesh Consumer Products Limited has informed the Exchange about the Link of Recording of Earnings Conference Call
Ganesh Consumer Products Limited has informed the Exchange about Schedule of meet
Ganesh Consumer Products Limited has informed the Exchange about Credit Rating
Promoter, director and designated-employee transactions in GANESHCP as reported to SEBI — buying and selling signals from the people who know the business best.
GANESHCP insider activity below tracks 6 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| - | Insider | 08 Jun 2026 | sell | −0 | — | — |
| - | Insider | 05 Jun 2026 | sell | −0 | — | — |
| - | Insider | 03 Jun 2026 | sell | −0 | — | — |
| Manish Mimani | Insider | 30 Mar 2026 | buy | +2.95 L | ₹5 Cr | ₹169.26 |
| Manish Mimani | Insider | 30 Mar 2026 | buy | +2.95 L | ₹5 Cr | ₹169.26 |
| Manish Mimani | Insider | 30 Mar 2026 | buy | +2.95 L | ₹5 Cr | ₹169.26 |
Every dividend, stock split and bonus issue GANESHCP has declared, sequenced by announce and record date.
GANESHCP corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What GANESHCP does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
GANESHCP operates in the Consumer Defensive.

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of this stock (GANESHCP) is ₹198.7. Today, the stock has gained by ₹0.52 (0.26%), trading in a range of ₹198.02 to ₹204.75. The stock opened at ₹200.29 with a trading volume of 81,923 shares.
this stock can be considered for long-term investment based on several factors. The company has a market capitalization of ₹800.26 crores, P/E ratio of 18.00, ROE of 14.19%, and ROCE of 0.00%. The dividend yield stands at 2.52%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of this stock (GANESHCP) is ₹0, while the 52-week low is ₹0. Currently trading at ₹198.7, the stock is Infinity% away from its 52-week low and -Infinity% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy this stock stock at ₹198.7 depends on multiple factors. The stock is currently trading with a P/E ratio of 18.00 and P/B ratio of 2.16. Today's performance shows a gain of 0.26%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
this stock offers a dividend yield of 2.52%, which means for every ₹100 invested at the current price of ₹198.7, you can expect to receive approximately ₹2.52 annually as dividends. The face value of the stock is ₹0.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
this stock's key financial metrics include: P/E Ratio: 18.00, P/B Ratio: 2.16, ROE: 14.19%, ROCE: 0.00%, Dividend Yield: 2.52%, EPS: ₹11.04, Book Value: ₹92.07, and Debt-to-Equity: 7.17. The company's market cap stands at ₹800.26 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
this stock stock opened at ₹200.29 and is currently trading at ₹198.7, showing a gain of ₹0.52 (0.26%). The intraday high is ₹204.75 and low is ₹198.02. The trading volume stands at 81,923 shares, indicating moderate market participation today.
this stock has a Price-to-Earnings (P/E) ratio of 18.00, which means investors are willing to pay ₹18.00 for every ₹1 of earnings. With an EPS of ₹11.04, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about the company (GANESHCP) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.